Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

PubWeight™: 3.83‹?› | Rank: Top 1%

🔗 View Article (PMID 16081640)

Published in Endocrinology on August 04, 2005

Authors

Anja Köster1, Y Bernice Chao, Marian Mosior, Amy Ford, Patricia A Gonzalez-DeWhitt, John E Hale, Deshan Li, Yubin Qiu, Christopher C Fraser, Derek D Yang, Josef G Heuer, S Richard Jaskunas, Patrick Eacho

Author Affiliations

1: Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46225, USA. koester_anja@lilly.com

Articles citing this

(truncated to the top 100)

Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet (2007) 13.78

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med (2010) 6.84

Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest (2008) 5.05

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med (2016) 3.88

A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet (2010) 3.78

Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab (2010) 2.95

Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci U S A (2006) 2.90

Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet (2009) 2.80

Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A (2012) 2.62

Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A (2013) 1.96

Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci U S A (2007) 1.88

Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A (2006) 1.79

Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab (2008) 1.79

Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One (2010) 1.70

Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem (2009) 1.64

Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem (2009) 1.64

Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes (2010) 1.61

Genetic causes of high and low serum HDL-cholesterol. J Lipid Res (2010) 1.55

Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev (2013) 1.49

Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes (2008) 1.48

The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem (2008) 1.44

Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol Cell Biol (2009) 1.41

GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J Lipid Res (2009) 1.33

Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood (2010) 1.30

Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab (2007) 1.27

Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem (2010) 1.19

Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol (2010) 1.13

Peroxisome proliferator activated receptors and lipoprotein metabolism. PPAR Res (2008) 1.12

A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization. J Biol Chem (2009) 1.12

New wrinkles in lipoprotein lipase biology. Curr Opin Lipidol (2012) 1.10

Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. J Biol Chem (2012) 1.09

GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J Lipid Res (2011) 1.08

Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Metabolism (2008) 1.08

ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. J Lipid Res (2015) 1.07

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab (2012) 1.03

Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J Biol Chem (2010) 1.03

Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. J Biol Chem (2013) 1.03

Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse. BMC Genomics (2007) 1.00

Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ. Mol Cell Biol (2013) 0.99

Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. J Lipid Res (2011) 0.96

Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans. PLoS One (2010) 0.94

Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiol (2012) 0.93

Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci (2008) 0.93

Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes. J Biol Chem (2013) 0.91

Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler Thromb Vasc Biol (2014) 0.89

Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription. PLoS Genet (2012) 0.89

A generalized genetic random field method for the genetic association analysis of sequencing data. Genet Epidemiol (2014) 0.88

Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res (2013) 0.88

Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci Lett (2007) 0.88

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. J Lipid Res (2015) 0.88

ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure. Elife (2015) 0.88

Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients (2016) 0.87

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. J Lipid Res (2016) 0.87

Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways. Exp Cell Res (2009) 0.87

Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes. BMC Med Genomics (2010) 0.86

Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus. PLoS One (2015) 0.85

Angiopoietin-like 4 regulates epidermal differentiation. PLoS One (2011) 0.85

Determination of lipoprotein lipase activity using a novel fluorescent lipase assay. J Lipid Res (2011) 0.85

Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity. Mol Metab (2014) 0.83

Adaptive ridge regression for rare variant detection. PLoS One (2012) 0.83

Hepatic ANGPTL3 regulates adipose tissue energy homeostasis. Proc Natl Acad Sci U S A (2015) 0.83

ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol (2013) 0.83

Angptl4 links α-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism. Proc Natl Acad Sci U S A (2015) 0.82

Genetics of lipid traits and relationship to coronary artery disease. Curr Cardiol Rep (2013) 0.82

A flexible likelihood framework for detecting associations with secondary phenotypes in genetic studies using selected samples: application to sequence data. Eur J Hum Genet (2011) 0.82

Angiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting. Adipocyte (2012) 0.81

A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase. Sci Rep (2015) 0.81

Insights from human congenital disorders of intestinal lipid metabolism. J Lipid Res (2014) 0.81

Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization. PLoS One (2013) 0.81

The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol (2016) 0.81

Repression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin. J Lipid Res (2014) 0.80

ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun (2016) 0.80

Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. J Lipid Res (2016) 0.80

Host biomarkers distinguish dengue from leptospirosis in Colombia: a case-control study. BMC Infect Dis (2014) 0.80

Analysis of multiple association studies provides evidence of an expression QTL hub in gene-gene interaction network affecting HDL cholesterol levels. PLoS One (2014) 0.79

Alterations in mouse hypothalamic adipokine gene expression and leptin signaling following chronic spinal cord injury and with advanced age. PLoS One (2012) 0.79

Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1. J Biol Chem (2015) 0.79

Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans. J Lipid Res (2013) 0.79

Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition. Proc Natl Acad Sci U S A (2017) 0.78

Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol (2014) 0.78

Cardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux. Biochim Biophys Acta (2011) 0.77

Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury. Am J Physiol Renal Physiol (2012) 0.77

ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells. Oncotarget (2015) 0.77

Transcriptome adaptation of the bovine mammary gland to diets rich in unsaturated fatty acids shows greater impact of linseed oil over safflower oil on gene expression and metabolic pathways. BMC Genomics (2016) 0.77

Lack of relationship between cord serum angiopoietin-like protein 4 (ANGPTL4) and lipolytic activity in human neonates born by spontaneous delivery. PLoS One (2013) 0.76

Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity. Nucl Receptor Res (2016) 0.75

Stabilizing lipoprotein lipase. J Lipid Res (2009) 0.75

Fasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism. Sci Rep (2016) 0.75

The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells. PLoS One (2017) 0.75

The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3. Mol Genet Metab (2016) 0.75

The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding. Elife (2016) 0.75

Distinct roles of angiopoietin-like 4 in the regulation of central and peripheral lipid metabolism? Mol Metab (2014) 0.75

Is there a link between proprotein convertase PC7 activity and human lipid homeostasis? FEBS Open Bio (2014) 0.75

Constraint and divergence of global gene expression in the mammalian embryo. Elife (2015) 0.75

Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting. Mol Metab (2017) 0.75

The C-terminal Fibrinogen-like Domain of Angiopoietin-like 4 Stimulates Adipose Tissue Lipolysis and Promotes Energy Expenditure. J Biol Chem (2017) 0.75

Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol (2017) 0.75

Effects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki Rats. Gene Regul Syst Bio (2017) 0.75

ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.75

ANGPLT3: A novel modulator of lipid metabolism. Glob Cardiol Sci Pract (2017) 0.75

Articles by these authors

FGF-21 as a novel metabolic regulator. J Clin Invest (2005) 10.69

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2003) 8.59

Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem (2004) 4.40

Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest (2007) 3.28

FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol (2008) 3.10

A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci U S A (2003) 2.47

GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42

Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet (2009) 2.37

Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res (2005) 1.81

Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science (2003) 1.77

New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62

Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta. Blood (2006) 1.51

Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 1.44

PK1/EG-VEGF induces monocyte differentiation and activation. J Leukoc Biol (2005) 1.38

Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem (2007) 1.36

The Ro autoantigen binds misfolded U2 small nuclear RNAs and assists mammalian cell survival after UV irradiation. Curr Biol (2003) 1.32

B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol (2005) 1.31

A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A (2003) 1.31

Estimating the statistical significance of peptide identifications from shotgun proteomics experiments. J Proteome Res (2007) 1.30

The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology (2012) 1.28

Maternal depression and developmental disability: research critique. Ment Retard Dev Disabil Res Rev (2007) 1.24

Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest (2007) 1.22

Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol (2007) 1.18

Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J Immunol (2008) 1.15

Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun (2002) 1.14

Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness. J Surg Res (2004) 1.13

The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics (2005) 1.12

Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med (2002) 1.10

Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol (2007) 1.10

Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. J Biol Chem (2005) 1.09

FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Endocrinology (2012) 1.05

The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab (2006) 1.03

Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug. Arthritis Res Ther (2009) 1.00

Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha. Endocrinology (2005) 0.99

Draft genomes of 12 host-adapted and environmental isolates of Pseudomonas aeruginosa and their positions in the core genome phylogeny. Pathog Dis (2013) 0.98

Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med (2003) 0.95

Label-free LC-MS method for the identification of biomarkers. Methods Mol Biol (2008) 0.93

A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. J Cell Biochem (2007) 0.92

Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics (2002) 0.92

Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Brief Funct Genomic Proteomic (2007) 0.92

Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulations. BMJ (2013) 0.91

Generation and characterization of neuregulin-2-deficient mice. Mol Cell Biol (2004) 0.91

Empirical science meets moral panic: an analysis of the politics of needle exchange. J Public Health Policy (2003) 0.91

Biochemical and kinetic characterization of BACE1: investigation into the putative species-specificity for beta- and beta'-cleavage sites by human and murine BACE1. J Neurochem (2004) 0.90

A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats. Endocrinology (2005) 0.89

Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biotechniques (2005) 0.89

Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg (2004) 0.88

A study of symptoms described by ovarian cancer survivors. Gynecol Oncol (2011) 0.86

Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol (2003) 0.85

An immuno-chemo-proteomics method for drug target deconvolution. J Proteome Res (2008) 0.84

Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. Int Immunopharmacol (2012) 0.83

Electrophoretic mobility of Alzheimer's amyloid-beta peptides in urea-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem (2003) 0.83

Endothelial lipase activity predicts high-density lipoprotein catabolism in hemodialysis: novel phospholipase assay in postheparin human plasma. Arterioscler Thromb Vasc Biol (2012) 0.82

A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing. J Am Soc Mass Spectrom (2014) 0.82

LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int Immunol (2003) 0.82

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy. Technol Cancer Res Treat (2013) 0.81

Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. Blood (2003) 0.80

Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J Proteome Res (2007) 0.80

Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. J Pharmacol Exp Ther (2008) 0.79

Transcriptional up-regulation of the signaling regulatory protein LNK in activated endothelial cells. Transplantation (2002) 0.79

Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses. Proteomics Clin Appl (2007) 0.79

Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study. Alcohol Clin Exp Res (2012) 0.79

FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis. Clin Vaccine Immunol (2006) 0.78

A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis. Int Immunopharmacol (2012) 0.78

Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways. Mol Cell Biochem (2015) 0.78

Rapid selection of differentially expressed genes in TNF[alpha]-activated endothelial cells. Mol Med (2002) 0.78

Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis. Mol Immunol (2013) 0.78

Inhibition of tumor growth by polyarginine-fused mutant cytosine deaminase. Appl Biochem Biotechnol (2014) 0.78

Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution. Expert Opin Drug Discov (2009) 0.78

From ghrelin to ghrelin's O-acyl transferase. Methods Enzymol (2012) 0.78

Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. J Proteome Res (2009) 0.77

Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells. J Immunol (2002) 0.77

Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin. J Pharmacol Exp Ther (2014) 0.77

Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). Prostaglandins Other Lipid Mediat (2005) 0.77

Gelation or molecular recognition; is the bis-(α,β-dihydroxy ester)s motif an omnigelator? Beilstein J Org Chem (2010) 0.77

Activated protein C modulates chemokine response and tissue injury in experimental sepsis. Adv Exp Med Biol (2008) 0.76

Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model. J Proteome Res (2007) 0.75

Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice. Endocrine (2015) 0.75

Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice. Biomark Insights (2008) 0.75

Correction: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect. PLoS One (2017) 0.75

Quantitative biological mass spectrometry. Editorial. Brief Funct Genomic Proteomic (2008) 0.75

[Improvement of yield and purity of human fibroblast growth factor-21]. Sheng Wu Gong Cheng Xue Bao (2014) 0.75

[Preparation and penetrating effect of the polyarginine-enhanced green fluorescence protein fusion protein]. Sheng Wu Gong Cheng Xue Bao (2013) 0.75

[Progress in using Newcastle disease virus for tumor therapy: a review]. Sheng Wu Gong Cheng Xue Bao (2010) 0.75

[Optimization of bacterial display technology based on antigen-antibody co-expression]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2013) 0.75

[Anti-tumor efficacy of P53 with 9R cell-penetrating peptides]. Sheng Wu Gong Cheng Xue Bao (2013) 0.75

Isolation of the neutralization ScFvs Against HBV infection from the Immunized Population. Curr Pharm Biotechnol (2015) 0.75

[Establishment of scFv antibody library screening technology based on flow cytometry]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2013) 0.75

[Expression and characterization of soluble recombinant Ulp1p with glutathione S-transferase tag in Escherichia coli]. Sheng Wu Gong Cheng Xue Bao (2010) 0.75

[Preparation of monoclonal antibodies against hFGF-21 and identification of epitope]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2013) 0.75

A neutralization scFv antibody against IL-1β isolated from a NIPA-based bacterial display library. Curr Pharm Biotechnol (2013) 0.75

[Construction of expression vectors for efficient expression of soluble recombinant proteins]. Sheng Wu Gong Cheng Xue Bao (2010) 0.75

Activation of caspase-3 alone is insufficient for apoptotic morphological changes in human neuroblastoma cells. J Neurochem (2002) 0.75